Screening for side effects of COVID-19 drug candidates on cardiovascular development -RAW DATA qPCR RESULTS

<p>Raw Data relating to Figures 4 and Supplemental Figures S7 and S8 of the article&nbsp;</p> <p><strong>Screening for side effects of COVID-19 drug candidates on cardiovascular development </strong></p> <p>Alexander Ernst^1#, Indre Piragyte^1,2#, Ayisha Marwa MP^1,2, Ngoc Dung Le³, Denis Grandgirard³, Stephen L. Leib³, Andrew Oates⁴, Nadia Mercader^1,2,5</p> <p>&nbsp;</p> <p>&nbsp;</p> <p>&nbsp;</p> <p>¹ Institute of Anatomy, University of Bern, Switzerland</p> <p>² Department for Biomedical Research DBMR, University of Bern, Switzerland</p> <p>³ Institute for Infectious Diseases, University of Bern, Switzerland</p> <p>⁴School of Life Sciences, &Eacute;cole polytechnique f&eacute;d&eacute;rale de Lausanne, Switzerland</p> <p>⁵ Centro Nacional de Investigaciones Cardiovasculares, CNIC, Madrid, Spain</p> <p># shared first-authorship</p>